$Health-related quality of life (HRQoL) with enasidenib versus conventional care regimens in older patients with late-stage mutant- IDH2 relapsed or refractory acute myeloid leukemia (R/R AML)$

Health-related quality of life (HRQoL) with enasidenib versus conventional care regimens in older patients with late-stage mutant- IDH2 relapsed or refractory acute myeloid leukemia (R/R AML)

Библиографические подробности
Главные авторы:	Dinardo, CD, Montesinos, P, Schuh, AC, Papayannidis, C, Vyas, P, Wei, AH, Zeidan, AM, Chen, C, Lord-Bessen, J, Yu, P, Shi, L, Guo, S, Bluemmert, I, Yu, X, Hasan, M, Martin Regueira, P, De Botton, S
Формат:	Journal article
Язык:	English
Опубликовано:	American Society of Clinical Oncology 2022

Схожие документы

Health-related quality of life (HRQoL) during treatment with enasidenib (ENA) plus azacitidine (AZA) in patients with newly diagnosed mutant IDH2 (m IDH2) acute myeloid leukemia (AML) not eligible for intensive chemotherapy (IC)
по: DiNardo, CD, и др.
Опубликовано: (2021)

Outcomes for patients with late-stage mutant-IDH2 (m IDH2) relapsed/refractory acute myeloid leukemia (R/R AML) treated with enasidenib vs other lower-intensity therapies in the randomized, phase 3 IDHentify Trial
по: DiNardo, CD, и др.
Опубликовано: (2021)

Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML
по: Risueño, A, и др.
Опубликовано: (2024)

AML-432 Overall survival (OS) by IDH2 mutant allele (R140 or R172) in patients with late-stage, mutant-IDH2 relapsed/refractory acute myeloid leukemia (AML) treated with enasidenib or conventional care regimens (CCR) in the randomized, open-label, Phase 3 IDHENTIFY Trial
по: DiNardo, CD, и др.
Опубликовано: (2022)

Overall survival by IDH2 mutant allele (R140 or R172) in patients with late-stage mutant- IDH2 relapsed or refractory acute myeloid leukemia treated with enasidenib or conventional care regimens in the phase 3 IDHENTIFY trial
по: De Botton, S, и др.
Опубликовано: (2022)

Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial
по: de Botton, S, и др.
Опубликовано: (2022)

A phase 3 study of Enasidenib (ENA) versus conventional care regimens (CCR) in older patients with late-stage mutant-IDH2 (MIDH2) relapsed/refractory acute myeloid leukemia (R/R AML)
по: Papayannidis, C, и др.
Опубликовано: (2021)

Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial
по: DiNardo, CD, и др.
Опубликовано: (2021)

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
по: Stein, EM, и др.
Опубликовано: (2017)

Self-reported health-related quality of life (HRQoL) and factors affecting HRQoL among individuals with health insurance in Iran
по: Ali Kazemi Karyani, и др.
Опубликовано: (2016-10-01)

Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib
по: Stein, EM, и др.
Опубликовано: (2018)

Clonal heterogeneity of acute Myeloid Leukemia treated with the IDH2 inhibitor Enasidenib
по: Vyas, P, и др.
Опубликовано: (2018)

The challenges of classical galactosemia: HRQoL in pediatric and adult patients
по: Merel E. Hermans, и др.
Опубликовано: (2023-06-01)

Higher perceived HRQoL in Moroccan children with asthma and their parents
по: Monique Theodora Maria Veenstra-van Schie, и др.
Опубликовано: (2015-05-01)

Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia
по: Keith W. Pratz, и др.
Опубликовано: (2022-04-01)

Clonal heterogeneity in differentiation response and resistance to the IDH2 inhibitor enasidenib in acute myeloid leukemia
по: Quek, L, и др.
Опубликовано: (2017)

Molecular features associated with response to enasidenib plus azacitidine in newly diagnosed IDH2-mutated acute myeloid leukemia
по: Risueño, A, и др.
Опубликовано: (2023)

HRQoL Evaluation of Pediatric Osteogenesis Imperfecta with Zoledronic Acid Therapy
по: Tri Wahyu Martanto, и др.
Опубликовано: (2023-10-01)

Socioeconomic inequalities in HRQoL in England: an age-sex stratified analysis
по: Paul Schneider, и др.
Опубликовано: (2022-08-01)

The association between diabetes mellitus and HRQoL of older people in Shanghai
по: Shiyin Tian, и др.
Опубликовано: (2021-11-01)

Health-Related Quality of Life (HRQoL) of Patients with Tuberculosis: A Review
по: Sandul Yasobant, и др.
Опубликовано: (2022-07-01)

The health gap and HRQoL inequalities in Greece before and during the economic crisis
по: John Yfantopoulos, и др.
Опубликовано: (2023-06-01)

Cough suppression and HRQoL in adult people with cystic fibrosis: an unexplored correlation
по: Ute Niehammer, и др.
Опубликовано: (2022-10-01)

Trait-Based Emotional Intelligence, Body Image Dissatisfaction, and HRQoL in Children
по: Olga Pollatos, и др.
Опубликовано: (2020-01-01)

Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes
по: Lesley Ann Saketkoo, и др.
Опубликовано: (2021-06-01)

Cosmetic Appeal, HRQoL, and Effectiveness of Simple and Pseudotesticular Techniques of Orchidectomy in Prostate Cancer
по: Ijeoma N. C. Chibuzo, и др.
Опубликовано: (2021-01-01)

Factors affecting health-related quality of life (HRQoL) in Pakistani children with thalassemia
по: Narjis Batool, и др.
Опубликовано: (2022-03-01)

Differential associations of sex and age with changes in HRQoL during outpatient cardiac rehabilitation
по: Lorenza L. S. Lanini, и др.
Опубликовано: (2024-01-01)

Impact of smoking status on health-related quality of life (HRQoL) in cancer survivors
по: José Ignacio Nolazco, и др.
Опубликовано: (2024-01-01)

Knowledge about Fibromyalgia in Fibromyalgia Patients and Its Relation to HRQoL and Physical Activity
по: María Mendoza-Muñoz, и др.
Опубликовано: (2021-07-01)

Waist–Calf Circumference Ratio Is an Independent Risk Factor of HRQoL in Centenarians
по: Yang S, и др.
Опубликовано: (2020-02-01)

Understanding the role of discriminative instruments in HRQoL research: can Ferguson's Delta help?
по: Wyrwich Kathleen W
Опубликовано: (2008-10-01)

Impact, distress and HRQoL among Malaysian men and women with a mobility impairment
по: Omar Zaliha, и др.
Опубликовано: (2006-12-01)

Measuring adolescents' HRQoL via self reports and parent proxy reports: an evaluation of the psychometric properties of both versions of the KINDL-R instrument
по: Ravens-Sieberer Ulrike, и др.
Опубликовано: (2009-08-01)

The potential impact of gene therapy on health-related quality of life (HRQoL) domains in haemophilia
по: Bullinger Monika, и др.
Опубликовано: (2021-05-01)

Gender disparities in health-related quality of life (HRQoL) in patients with cutaneous T-cell lymphoma
по: Christopher W. Chalaka, MD, и др.
Опубликовано: (2023-06-01)

Predicting panel attrition in longitudinal HRQoL surveys during the COVID-19 pandemic in the US
по: Tianzhou Yu, и др.
Опубликовано: (2022-07-01)

Weight associated factors in relation to health-related quality of life (HRQoL) in Iranian adolescents
по: Sara Jalali-Farahani, и др.
Опубликовано: (2019-01-01)

Health-Related Quality of Life (HRQoL) in Idiopathic Inflammatory Myopathy: A Systematic Review.
по: Valérie Leclair, и др.
Опубликовано: (2016-01-01)

Using self-determination theory to predict self-management and HRQoL in moderate-to-severe COPD
по: Liam Knox, и др.
Опубликовано: (2021-01-01)